Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 141
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT07647510 A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Mya… |
Claseprubart | Myasthénie | Phase 3 | RECRUITING | En attente / non publié | Dianthus Therapeutics | United States · Cinical Study Site, Boca Raton, Unite… | 2026-06-29 → 2031-09 | Ouvrir |
| NCT06149559 roMyG — A Study of Rozanolixizumab in Pediatric Study Participants With… |
rozanolixizumab | Myasthénie | Phase 2/3 | ACTIVE_NOT_RECRUITING | En attente / non publié | UCB Biopharma SRL | Italy, Japan, Poland, Turkey (Türkiye) · Mg0006 20339… | 2024-06-14 → 2026-10-05 | Ouvrir |
| NCT00716066 Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases |
Anti-Thymocyte Globulin | Myasthénie | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Fred Hutchinson Cancer Center | United States · Colorado Blood Cancer Institute, Denv… | 2008-06 → 2030-01-31 | Ouvrir |
| NCT07298928 A Study on the Efficacy and Safety of Telitacicept in the Treatment of … |
Telitacicept | Myasthénie | Non applicable | NOT_YET_RECRUITING | En attente / non publié | The Children's Hospital of Zhejia… | China · Children's Hospital Affiliated to Shandong Un… | 2026-03-10 → 2028-12 | Ouvrir |
| NCT06909214 ADAPT-EARLY — A Study to Evaluate the Clinical Outcomes of Efgartigimod… |
Efgartigimod PH20 SC | Myasthénie | Phase 4 | RECRUITING | En attente / non publié | argenx | United States · Baycare Medical Group, St. Petersburg… | 2025-04-17 → 2027-05 | Ouvrir |
| NCT07470151 Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Di… |
EVM18001 Injection | Myasthénie | Non applicable | RECRUITING | En attente / non publié | Union Hospital, Tongji Medical Co… | China · Union Hospital Tongji Medical College HUAZHON… | 2026-03-12 → 2027-12 | Ouvrir |
| NCT07472777 Long-term Efficacy of Modified Guilu Erxian Glue for Myasthenia Gravis |
Long-term Efficacy of Modified Gu… | Myasthénie | À vérifier | COMPLETED | En attente / non publié | Beijing University of Chinese Med… | China · The First Affiliated Hospital of Henan Univer… | 2024-01-01 → 2024-07-31 | Ouvrir |
| NCT07478172 Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults … |
Whole-body Electrical Muscle Stim… | Myasthénie | Non applicable | RECRUITING | En attente / non publié | University of Missouri-Columbia | United States · NextGen Precision Health Building, Cl… | 2026-03-10 → 2031-01-07 | Ouvrir |
| NCT07413835 Efficacy and Safety of HN2302 in Refractory Myasthenia Gravis(MG) |
HN2302 Injection | Myasthénie | Non applicable | RECRUITING | En attente / non publié | The Affiliated Hospital of Xuzhou… | China · The Affiliated Hospital of Xuzhou Medical Uni… | 2026-03-17 → 2027-12 | Ouvrir |
| NCT06491238 MG-Ex — Light vs. Moderate Intensity Exercise in Individuals With Myast… |
MG-Ex — Light vs. Moderate Intens… | Myasthénie | Non applicable | RECRUITING | En attente / non publié | HealthPartners Institute | United States · HealthPartners Neuroscience Center, S… | 2024-09-16 → 2026-12 | Ouvrir |
| NCT06607627 PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients… |
Gefurulimab | Myasthénie | Phase 3 | RECRUITING | En attente / non publié | Alexion Pharmaceuticals, Inc. | United States, Brazil, Japan, Poland, Taiwan · Resear… | 2024-11-13 → 2029-01-23 | Ouvrir |
| NCT07512375 MY-EDUC — The Effectiveness of an ETP Programme in Myasthenia Gravis: a… |
MY-EDUC — The Effectiveness of an… | Myasthénie | À vérifier | NOT_YET_RECRUITING | En attente / non publié | University Hospital, Grenoble | Non communiqué | 2026-04 → 2027-06 | Ouvrir |
| NCT07499323 Talquetamab in Patients With Refractory Generalized Myasthenia Gravis |
Talquetamab | Myasthénie | Non applicable | NOT_YET_RECRUITING | En attente / non publié | First Affiliated Hospital of Chon… | Non communiqué | 2026-03-20 → 2027-04-01 | Ouvrir |
| NCT07249632 A Study of Telitacicept in Patients With Ocular Myasthenia Gravis (OMG) |
Telitacicept | Myasthénie | Phase 3 | RECRUITING | En attente / non publié | The Children's Hospital of Zhejia… | China · Beijing Hospital, Beijing, China | 2026-01-13 → 2027-02-28 | Ouvrir |
| NCT06754020 TCM Tongue Diagnosis and Syndrome Differentiation in Myasthenia Gravis … |
Heart Rate Variability,HRV - ANSW… | Myasthénie | Non applicable | RECRUITING | En attente / non publié | Yi Ting Yeh | Taiwan · Yi Ting Yeh, New Taipei City, Taiwan | 2023-01-17 → 2027-12-31 | Ouvrir |
| NCT06312644 Study of Ultomiris® (Ravulizumab) Safety in Pregnancy |
Ultomiris | Myasthénie | À vérifier | RECRUITING | En attente / non publié | Alexion Pharmaceuticals, Inc. | United States, Australia, France, Germany, Italy, Sou… | 2024-12-16 → 2034-07-11 | Ouvrir |
| NCT07532707 Efficacy of IVIG Versus PLEX in Myasthenic Crisis in Syria. |
IVIG (Intravenous Immunoglobulin) | Myasthénie | Non applicable | COMPLETED | En attente / non publié | Damascus University | Syria · Damascus University, Damascus, Syria | 2022-09-01 → 2023-10-30 | Ouvrir |
| NCT05644561 Evaluation of PK, PD, Efficacy, Safety, and Immunogenicity of IV Ravuli… |
Ravulizumab | Myasthénie | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | AstraZeneca | United States, Italy, Japan, Serbia, Switzerland · Re… | 2023-06-24 → 2028-06-30 | Ouvrir |
| NCT05332210 Evaluate the Safety of HBM9161 (HL161) Subcutaneous Injection in Patien… |
HBM9161 Injection (680mg) | Myasthénie | Phase 3 | COMPLETED | En attente / non publié | Harbour BioMed (Guangzhou) Co. Lt… | China · Huashan Hospital, Fudan University, Shanghai,… | 2022-06-30 → 2024-04-26 | Ouvrir |
| NCT06220201 A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels… |
CC-97540 | Myasthénie | Phase 1 | ACTIVE_NOT_RECRUITING | En attente / non publié | Juno Therapeutics, Inc., a Bristo… | United States, Belgium, France, Germany, Spain, Unite… | 2024-03-28 → 2027-07-15 | Ouvrir |
| NCT05374590 ADAPT Jr + — Evaluating Long-term Safety of Efgartigimod Administered I… |
Efgartigimod IV or Efgartigimod P… | Myasthénie | Phase 2/3 | ENROLLING_BY_INVITATION | En attente / non publié | argenx | United States, Belgium, Canada, France, Germany, Isra… | 2022-08-18 → 2029-09 | Ouvrir |
| NCT07304154 A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refr… |
KITE-363 | Myasthénie | Phase 1 | RECRUITING | En attente / non publié | Kite, A Gilead Company | United States, Australia, Canada · Columbia Universit… | 2026-04-10 → 2029-06 | Ouvrir |
| NCT06106672 Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP… |
CNP-106 | Myasthénie | Phase 1/2 | ACTIVE_NOT_RECRUITING | En attente / non publié | COUR Pharmaceutical Development C… | United States · Atlantis Research, Miami, United Stat… | 2024-05-30 → 2026-08 | Ouvrir |
| NCT06193889 KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, … |
Standard lymphodepletion regimen | Myasthénie | Phase 2/3 | RECRUITING | En attente / non publié | Kyverna Therapeutics | United States, Australia, Brazil, Germany, Saudi Arab… | 2024-08-28 → 2028-09 | Ouvrir |
| NCT06940323 Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA) |
Pregnancy Registry, Infants, Seru… | Myasthénie | À vérifier | RECRUITING | En attente / non publié | University of California, San Fra… | United States · University of California-San Francisc… | 2017-03-21 → 2035-06 | Ouvrir |